Boston Scientific (BSX) Tops Q4 EPS by 4c, Beats on Revenue; Offers FY25 EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Wall St set for lower open as AI jitters rekindle, oil gains
- Brent hits five-month high on escalating Middle East conflict
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- JPMorgan says AI stock selling may be nearing its limit as positioning resets
Tweet
Share
E-mail
Get Alerts BSX Hot Sheet
Price: $44.99 +1.08%
Revenue Growth %: +1.0%
Financial Fact:
Net income (loss) per common share - basic: 0.17
Today's EPS Names:
SICP, MNSB, CFFI, More
Revenue Growth %: +1.0%
Financial Fact:
Net income (loss) per common share - basic: 0.17
Today's EPS Names:
SICP, MNSB, CFFI, More
Join SI Premium – FREE
Boston Scientific (NYSE: BSX) reported Q4 EPS of $0.70, $0.04 better than the analyst estimate of $0.66. Revenue for the quarter came in at $4.56 billion versus the consensus estimate of $4.41 billion.
GUIDANCE:
Boston Scientific sees FY2025 EPS of $2.80-$2.87, versus the consensus of $2.81.
For earnings history and earnings-related data on Boston Scientific (BSX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UBS Reiterates Neutral Rating on Nike (NKE) on Expected Pace of Earnings Recovery
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- AMD shares fall amid AI chip sector selloff
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
